--- title: "Vivani Medical (VANI) news: offering" url: "https://aibio.space/companies/vivani-medical/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "VANI offering news: Vivani Medical prices $4.5 million stock offering; chairman's affiliate to buy $2.0 million. Vivani Medical, Inc." --- VANI Vivani Medical, Inc. NASDAQ · United States # Vivani Medical (VANI) news VANI offering news Financings · 2026-01-27 ## [Vivani Medical prices $4.5 million stock offering; chairman's affiliate to buy $2.0 million](https://aibio.space/news/vivani-medical-prices-4-5-million-stock-offering-chairmans-affiliate/) Vivani will sell 1,689,200 shares in a registered direct offering and 1,351,351 shares in a private placement at $1.48 each. ThinkEquity is sole placement agent for the registered part, and the company used $20,786 thousand in operations in 2024 against $19,690 thousand of year-end cash. ## Latest Vivani Medical news 1. 2025-08-13 Financings [Vivani Medical agrees to sell 7,936,507 shares at $1.26 in private placement of about $10.0 million](https://aibio.space/news/vivani-medical-agrees-sell-7-936-507-shares-1-26-private-placement/) Vivani's Share Purchase Agreement with an entity affiliated with a director and another investor is expected to close in stages through July 15, 2026. The company says the proceeds secure its financial position into the second half of 2026. 2. 2025-08-13 Financings [Vivani Medical agrees $10.0 million private placement at $1.26 per share](https://aibio.space/news/vivani-medical-agrees-10-0-million-private-placement-1-26-share/) Vivani sells 7,936,507 shares at $1.26 to two buyers, one of them tied to chairman Gregg Williams. Cash was $8.1 million at June 30, 2025, and the release presents the new money as securing its position into the second half of 2026. ## Vivani Medical at a glance - **Ticker**: VANI - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $19.9 million ### Related companies - [Trafalgar International](https://aibio.space/companies/trafalgar-international/) OTC: TRFA - [AN2 Therapeutics](https://aibio.space/companies/an2-therapeutics/) NASDAQ: ANTX - [Insmed](https://aibio.space/companies/insmed/) NASDAQ: INSM - [Aktis Oncology](https://aibio.space/companies/aktis-oncology/) NASDAQ: AKTS - [MabCure](https://aibio.space/companies/mabcure/) OTC: MBCI - [Biohaven](https://aibio.space/companies/biohaven/) NYSE: BHVN - [Skinvisible](https://aibio.space/companies/skinvisible/) OTC: SKVI - [Biogen](https://aibio.space/companies/biogen/) NASDAQ: BIIB ### Also on NASDAQ - [BIO-TECHNE](https://aibio.space/companies/bio-techne/) TECH - [ARS Pharmaceuticals](https://aibio.space/companies/ars-pharmaceuticals/) SPRY - [Latigo Biotherapeutics](https://aibio.space/companies/latigo-biotherapeutics/) LTGO - [Lumexa Imaging Holdings](https://aibio.space/companies/lumexa-imaging/) LMRI - [Alnylam Pharmaceuticals](https://aibio.space/companies/alnylam-pharmaceuticals/) ALNY - [Redhill Biopharma](https://aibio.space/companies/redhill-biopharma/) RDHL ## Vivani Medical annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$18.1 million](https://www.sec.gov/Archives/edgar/data/1266806/000175392626000548/) | [$15.7 million](https://www.sec.gov/Archives/edgar/data/1266806/000175392626000548/) | | Net income (loss) | [-$26.6 million](https://www.sec.gov/Archives/edgar/data/1266806/000175392626000548/) | [-$23.5 million](https://www.sec.gov/Archives/edgar/data/1266806/000175392626000548/) | | Cash from operations | [-$24.3 million](https://www.sec.gov/Archives/edgar/data/1266806/000175392626000548/) | [-$20.8 million](https://www.sec.gov/Archives/edgar/data/1266806/000175392626000548/) | | Cash and equivalents | [$16.2 million](https://www.sec.gov/Archives/edgar/data/1266806/000175392626001477/) | [$18.4 million](https://www.sec.gov/Archives/edgar/data/1266806/000175392626000548/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $19.9 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Vivani Medical Has Vivani Medical raised money recently? Our latest story on this, dated Jan 27, 2026: "Vivani Medical prices $4.5 million stock offering; chairman's affiliate to buy $2.0 million". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/vivani-medical-prices-4-5-million-stock-offering-chairmans-affiliate/). What is the ticker symbol of Vivani Medical? Vivani Medical, Inc. trades under the ticker VANI on NASDAQ. Where is Vivani Medical listed? Vivani Medical, Inc. is listed on NASDAQ. Our directory also records these other listings: GETTEX:U5P. What is the SEC CIK of Vivani Medical? The SEC Central Index Key (CIK) for Vivani Medical, Inc. is 1266806. Its filings are on SEC EDGAR. How many shares does Vivani Medical have outstanding? 90,203,356 shares as of 2026-08-13, per the cover page of its 10-Q filed 2026-08-13. Which country or territory is Vivani Medical listed under? Our directory records Vivani Medical, Inc. under United States. What does Vivani Medical do? Our directory classifies Vivani Medical, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Vivani Medical? The ISIN recorded for Vivani Medical, Inc. is US92854B1098. Does aibio.space cover Vivani Medical? aibio.space lists Vivani Medical, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Vivani Medical incorporated? SEC records list its state or country of incorporation as DE. Is Vivani Medical profitable? Vivani Medical, Inc. reported a net loss of $26.6 million for the fiscal year ended Dec 31, 2025, and used $24.3 million of cash in operations, per its annual report to the SEC. How much does Vivani Medical spend on research and development? $18.1 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Vivani Medical have? $19.9 million in cash at Jun 30, 2026, per its 10-Q. What is the latest Vivani Medical (VANI) stock news? Our latest story on Vivani Medical, dated Jan 27, 2026: "Vivani Medical prices $4.5 million stock offering; chairman's affiliate to buy $2.0 million". Vivani will sell 1,689,200 shares in a registered direct offering and 1,351,351 shares in a private placement at $1.48 each. ThinkEquity is sole placement agent for the registered part, and the company used $20,786 thousand in operations in 2024 against $19,690 thousand of year-end cash. [Source](https://aibio.space/news/vivani-medical-prices-4-5-million-stock-offering-chairmans-affiliate/). How long will Vivani Medical's cash last? From our story of Jan 27, 2026: The report says the financial statements are prepared on a going-concern basis. [Source](https://aibio.space/news/vivani-medical-prices-4-5-million-stock-offering-chairmans-affiliate/). ## Investor discussion: Vivani Medical Members talk about Vivani Medical (VANI). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Vivani Medical, newest first. Each line links the filing it comes from. 1. 2026-08-13 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1266806/000175392626001477/vani-20260630.htm) 2. 2026-07-07 Mergers Reported a merger or acquisition agreement. SEC Form 8-K (Items 1.01,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1266806/000175392626001144/ex991_2.htm) 3. 2026-06-30 Financings Reported a financing. SEC Form 8-K (Items 5.02,5.07,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1266806/000175392626001109/ex991_2.htm) 4. 2026-01-27 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1266806/000175392626000186/MainDocument.htm) 5. 2025-10-28 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1266806/000175392625001653/MainDocument.htm) 6. 2025-08-13 Financings Reported a financing. SEC Form 8-K (Items 1.01,2.02,3.02,7.01,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1266806/000175392625001328/ex991_2.htm) 7. 2025-05-13 Financings Reported a financing. SEC Form 8-K (Items 1.01,2.02,3.02,7.01,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1266806/000175392625000792/ex991_2.htm) 8. 2025-03-27 Financings Reported a financing. SEC Form 8-K (Items 1.01,3.02,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1266806/000175392625000495/ex991_2.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:VANI on TradingView](https://www.tradingview.com/symbols/NASDAQ-VANI/). ## SEC filings and registration - **SEC name**: Vivani Medical, Inc. - **CIK**: 1266806 - **Industry (SIC)**: Electromedical & Electrotherapeutic Apparatus (3845) - **US tickers**: VANI (Nasdaq) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer
Smaller reporting company - **Business address**: 1350 S. LOOP ROAD, ALAMEDA, CA, 94502 - **Phone**: 415-506-8462 - **Shares outstanding**: 90,203,356 as of 2026-08-13 (10-Q filed 2026-08-13) - **Former names**: SECOND SIGHT MEDICAL PRODUCTS INC; SECOUND SIGHT MEDICAL PRODUCTS INC ### Recent filings (8-K and 6-K are the company's own announcements) - [424B5](https://www.sec.gov/Archives/edgar/data/1266806/000175392626001863/MainDocument.htm) filed 2026-09-25 - [8-K](https://www.sec.gov/Archives/edgar/data/1266806/000175392626001808/vani-20260916.htm) filed 2026-09-16 - [8-K](https://www.sec.gov/Archives/edgar/data/1266806/000175392626001536/vani-20260817.htm) filed 2026-08-17 - [8-K](https://www.sec.gov/Archives/edgar/data/1266806/000175392626001482/vani-20260813.htm) filed 2026-08-13 - [10-Q](https://www.sec.gov/Archives/edgar/data/1266806/000175392626001477/vani-20260630.htm) filed 2026-08-13 - [8-K](https://www.sec.gov/Archives/edgar/data/1266806/000175392626001349/vani-20260806.htm) filed 2026-08-06 - [8-K](https://www.sec.gov/Archives/edgar/data/1266806/000175392626001190/vani-20260715.htm) filed 2026-07-16 - [8-K](https://www.sec.gov/Archives/edgar/data/1266806/000175392626001144/vani-20260701.htm) filed 2026-07-07 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001266806), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Vivani Medical, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker VANI, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Vivani Medical, Inc. - **Ticker**: VANI - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Pharmaceuticals: Major - **ISIN**: US92854B1098 - **Other listed symbols**: GETTEX:U5P - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-VANI/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/vivani-medical/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Vivani Medical (VANI) news: offering", 2026-10-31, https://aibio.space/companies/vivani-medical/